|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.61 HKD | -10.29% |
|
-22.78% | -41.90% |
| 03-28 | Viva Biotech Holdings Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-18 | Viva Biotech Holdings Appoints WANG Stephen Hui as Non-Executive Director | CI |
Viva Biotech Holdings entered into the Bonds Subscription Agreement of convertible bonds of HKD 470 million on June 10, 2023. The interest rate of convertible bonds is 2%. The conversion price is HKD 2 per share.
The maturity date is November 30, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -41.90% | 187M | |
| +38.69% | 728B | |
| +34.28% | 603B | |
| -4.49% | 360B | |
| +20.24% | 332B | |
| +2.12% | 279B | |
| +17.02% | 244B | |
| +9.31% | 207B | |
| -5.07% | 205B | |
| -0.35% | 163B |
VIVA BIOTECH HOLDINGS 
